The authors describe a patient with hypertrophic obstructive cardiomyopathy (HOCM) with decrease in septum thickness following procainamide treatment.
Get full access to this article
View all access options for this article.
References
1.
Hartmann A., Kaltenbach M., Hopf R.: Drug therapy of hypertrophic cardiomyopathy. Fortshcr Med110:485-488, 1992.
2.
Marcaggi X., Barraud P., Schandrin C., et al: Primary hypertrophic cardiomyopathies. Diagnosis and treatment. Rev Pract40:2219-2226, 1990 .
3.
Louie EK, Maron BJ: Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness ; functional and morphologic features and clinical significance . J Am Coll Cardiol8:57-65, 1986.
4.
Spirito P., Maron BJ, Bonow RO, et al: Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy. J Am Coll Cardiol8:537-544, 1986.
5.
Blachard DG, Ross J.Jr: Hypertrophic cardiomyopathy prognosis with medical or surgical therapy . Clin Cardiol14:11-19, 1991.
6.
Seiler C., Hess OM, Schoenbeck M., et al: Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: A retrospective study. J Am Coll Cardiol17:634-642, 1991.
7.
Curtius JM, Stoecker J., Loesse B., et al: Changes of the degree of hypertrophy in hypertrophic obstructive cardiomyopathy under medical and surgical treatment. Cardiology76:255-263, 1989.
8.
Pearce PC, Hawkey CM, Symons C., et al: The importance of membrane stabilization in protecting the developing rat myocardium from the action of triac. Am J Cardiovasc Pathol2:173-179, 1988.
